CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 82 enrolled
Drug / intervention
Radiation therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00836186
NCT00836186N/ACompleted

Cytokine Expression During Radiation for Breast Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins·interventional·Posted Feb 4, 2009·Updated Oct 8, 2020

In Brief

A clinical study evaluating Radiation therapy for Breast Cancer. Completed, enrolled 82 participants across 2 sites.

Detailed Summary

To assess the magnitude and frequency of changes in chemo/cytokine expression in women receiving radiation treatment. To asses the impact of race/ethnicity on the magnitude and frequency of changes in chemo/cytokine expression during radiation therapy for breast cancer. And finally to assess the interaction between radiation-induced chemo/cytokine expression changes, and race/ethnicity, with respect to normal tissue reactions to radiation and tumor-associated outcomes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 4, 2009
Enrollment StartNov 13, 2009
Primary CompletionNov 26, 2014
Study CompletionNov 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 17.4 years ago

Interventions

Radiation therapyradiation

Patients will receive whole breast radiation therapy at a dose of 180-200 centigray (cGy) per fraction for 23-27 fractions to a total dose of 4600 - 4860 cGy. Additional radiation to the lumpectomy bed (Boost) is at the discretion of the treating physician. The total dose to the tumor bed cannot exceed 6600 cGy.